BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32349021)

  • 1. The Population-based Impact of Adjuvant Chemotherapy on Outcomes in T2N0M0 Non-Small Cell Lung Cancer.
    Arora RK; Gibson AW; Bebb DG; Cheung WY
    Am J Clin Oncol; 2020 Jul; 43(7):496-503. PubMed ID: 32349021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC.
    Morgensztern D; Du L; Waqar SN; Patel A; Samson P; Devarakonda S; Gao F; Robinson CG; Bradley J; Baggstrom M; Masood A; Govindan R; Puri V
    J Thorac Oncol; 2016 Oct; 11(10):1729-35. PubMed ID: 27287414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Chemotherapy in Resected Stage II Non-small Cell Lung Cancer: Evaluating the Impact of Dose Intensity and Time to Treatment.
    Ramsden K; Laskin J; Ho C
    Clin Oncol (R Coll Radiol); 2015 Jul; 27(7):394-400. PubMed ID: 25800720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
    Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
    J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
    Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR
    J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy for elderly patients with non-small-cell lung cancer.
    Yamanashi K; Okumura N; Yamamoto Y; Takahashi A; Nakashima T; Matsuoka T; Kameyama K
    Asian Cardiovasc Thorac Ann; 2017 Jun; 25(5):371-377. PubMed ID: 28592139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy Following Lobectomy for Non-small Cell Lung Cancers Larger than 4 cm.
    Sandler BJ; Wang Z; Hancock JG; Boffa DJ; Detterbeck FC; Kim AW
    Ann Surg Oncol; 2016 Feb; 23(2):638-45. PubMed ID: 26474557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy for visceral pleural invasion in 3-4-cm non-small-cell lung cancer improves survival.
    Wightman SC; Lee JY; Ding L; Atay SM; Shemanski KA; McFadden PM; David EA; Kim AW
    Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35325098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity score-matched analysis of adjuvant chemotherapy for stage I non-small cell lung cancer.
    Tsutani Y; Miyata Y; Kushitani K; Takeshima Y; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1179-85. PubMed ID: 25112928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER-Medicare analysis.
    Malhotra J; Mhango G; Gomez JE; Smith C; Galsky MD; Strauss GM; Wisnivesky JP
    Ann Oncol; 2015 Apr; 26(4):768-773. PubMed ID: 25600562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of adjuvant chemotherapy after resection of stage II (T1-2N1M0) non-small cell lung cancer in elderly patients.
    Berry MF; Coleman BK; Curtis LH; Worni M; D'Amico TA; Akushevich I
    Ann Surg Oncol; 2015 Feb; 22(2):642-8. PubMed ID: 25192680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant Systemic Therapy in Patients With Early-Stage NSCLC Treated With Stereotactic Body Radiation Therapy.
    Ernani V; Appiah AK; Marr A; Zhang C; Zhen W; Smith LM; Ganti AK
    J Thorac Oncol; 2019 Mar; 14(3):475-481. PubMed ID: 30503890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
    Tanaka F; Miyahara R; Ohtake Y; Yanagihara K; Fukuse T; Hitomi S; Wada H
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database.
    Moreno AC; Morgensztern D; Yu JB; Boffa DJ; Decker RH; Detterbeck FC; Kim AW
    J Surg Res; 2013 Sep; 184(1):10-8. PubMed ID: 23583079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada.
    Cuffe S; Booth CM; Peng Y; Darling GE; Li G; Kong W; Mackillop WJ; Shepherd FA
    J Clin Oncol; 2012 May; 30(15):1813-21. PubMed ID: 22529258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of age on the efficacy of adjuvant chemotherapy for resected non-small cell lung cancer.
    Ganti AK; Williams CD; Gajra A; Kelley MJ
    Cancer; 2015 Aug; 121(15):2578-85. PubMed ID: 25873330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival benefit of thermal ablation combined with chemotherapy for the treatment of stage IV nonsmall cell lung cancer: a propensity-matched analysis.
    Yang H; Li M; Mei T
    Int J Hyperthermia; 2022; 39(1):348-357. PubMed ID: 35164638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who are the real high-risk patients with pathological T2N0M0 non-small-cell lung cancer that can benefit from adjuvant chemotherapy?
    Hou X; Yang MZ; Li JB; Tan ZH; Long H; Fu JH; Zhang LJ; Lin P; Yang HX
    ESMO Open; 2022 Jun; 7(3):100508. PubMed ID: 35688064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected.
    Ren Y; Dai C; Shen J; Liu Y; Xie D; Zheng H; He J; Liang W; Jiang G; Fei K; Yang P; He J; Chen C
    Oncotarget; 2016 May; 7(18):26856-65. PubMed ID: 27057627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.